Knight Mergers & Acquisitions

Knight M&A Summary

Knight has acquired 3 companies, including 1 in the last 5 years. It has also divested 1 asset.

Knight’s largest acquisition to date was in 2020, when it acquired Grupo Farmaceutico Biotoscana S.A. for $143M. It’s largest disclosed sale occurred in 2020, when it sold Grupo Farmaceutico Biotoscana S.A. to Knight Therapeutics for $143M. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity2
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Knight

Knight Therapeutics, Inc.

3400 De Maisonneuve Boulevard West, Suite 1055,
Montreal, Quebec H3Z 3B8
Canada,
(514) 484-4483
www.knighttx.com

All (3) Buy (2) Sell (1)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2020-08-14 Grupo Farmaceutico Biotoscana · Life Science
Montevideo, Uruguay · www.grupobiotoscana.com

Grupo Farmaceutico Biotoscana is a biopharmaceutical group that focuses on rapidly growing market segments such as infectious diseases, oncology and onco-hematology, special treatments, immunology and inflammation, and orphan/rare diseases, among others. Grupo Farmaceutico Biotoscana was formed in 1994 and is based in Montevideo, Uruguay.

143 Add-on Acquisition

Knight

Knight


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.